These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 24898981)

  • 1. Topical paromomycin and gentamicin for new world cutaneous leishmaniasis in Panama.
    Monge-Maillo B; López-Vélez R
    Am J Trop Med Hyg; 2014 Jun; 90(6):1191. PubMed ID: 24898981
    [No Abstract]   [Full Text] [Related]  

  • 2. Randomized, double-blinded, phase 2 trial of WR 279,396 (paromomycin and gentamicin) for cutaneous leishmaniasis in Panama.
    Sosa N; Capitán Z; Nieto J; Nieto M; Calzada J; Paz H; Spadafora C; Kreishman-Deitrick M; Kopydlowski K; Ullman D; McCarthy WF; Ransom J; Berman J; Scott C; Grogl M
    Am J Trop Med Hyg; 2013 Sep; 89(3):557-563. PubMed ID: 23857024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topical paromomycin for New World cutaneous leishmaniasis.
    Sosa N; Pascale JM; Jiménez AI; Norwood JA; Kreishman-Detrick M; Weina PJ; Lawrence K; McCarthy WF; Adams RC; Scott C; Ransom J; Tang D; Grogl M
    PLoS Negl Trop Dis; 2019 May; 13(5):e0007253. PubMed ID: 31048871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topical paromomycin with or without gentamicin for cutaneous leishmaniasis.
    Ben Salah A; Ben Messaoud N; Guedri E; Zaatour A; Ben Alaya N; Bettaieb J; Gharbi A; Belhadj Hamida N; Boukthir A; Chlif S; Abdelhamid K; El Ahmadi Z; Louzir H; Mokni M; Morizot G; Buffet P; Smith PL; Kopydlowski KM; Kreishman-Deitrick M; Smith KS; Nielsen CJ; Ullman DR; Norwood JA; Thorne GD; McCarthy WF; Adams RC; Rice RM; Tang D; Berman J; Ransom J; Magill AJ; Grogl M
    N Engl J Med; 2013 Feb; 368(6):524-32. PubMed ID: 23388004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics and absorption of paromomycin and gentamicin from topical creams used to treat cutaneous leishmaniasis.
    Ravis WR; Llanos-Cuentas A; Sosa N; Kreishman-Deitrick M; Kopydlowski KM; Nielsen C; Smith KS; Smith PL; Ransom JH; Lin YJ; Grogl M
    Antimicrob Agents Chemother; 2013 Oct; 57(10):4809-15. PubMed ID: 23877689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful topical treatment of murine cutaneous leishmaniasis with a combination of paromomycin (Aminosidine) and gentamicin.
    Grogl M; Schuster BG; Ellis WY; Berman JD
    J Parasitol; 1999 Apr; 85(2):354-9. PubMed ID: 10219319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In response.
    Grogl M; Sosa N; Kreishman-Deitrick M
    Am J Trop Med Hyg; 2014 Jun; 90(6):1192. PubMed ID: 24898982
    [No Abstract]   [Full Text] [Related]  

  • 8. Topical treatment of New World cutaneous leishmaniasis in Belize: a clinical study.
    Weinrauch L; Cawich F; Craig P; Sosa JX; el-On J
    J Am Acad Dermatol; 1993 Sep; 29(3):443-6. PubMed ID: 8349861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Topical treatment of persistent cutaneous leishmaniasis with paromomycin].
    Flaig MJ; Rupec J; Ruzicka T; Rupec RA
    Hautarzt; 2007 Aug; 58(8):689-90, 692. PubMed ID: 17676349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Successful topical treatment of chronic cutaneous leishmaniasis with paromomycin sulfate (15%) and methylbenzethonium chloride (12%)].
    Schallreuter KU; Lemke KR
    Hautarzt; 1994 Nov; 45(11):783-6. PubMed ID: 7822205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topical paromomycin/methylbenzethonium chloride plus parenteral meglumine antimonate as treatment for American cutaneous leishmaniasis: controlled study.
    Soto J; Fuya P; Herrera R; Berman J
    Clin Infect Dis; 1998 Jan; 26(1):56-8. PubMed ID: 9455509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful treatment of New World cutaneous leishmaniasis with a combination of topical paromomycin/methylbenzethonium chloride and injectable meglumine antimonate.
    Soto J; Hernandez N; Mejia H; Grogl M; Berman J
    Clin Infect Dis; 1995 Jan; 20(1):47-51. PubMed ID: 7727669
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of cutaneous leishmaniasis with either topical paromomycin or intralesional meglumine antimoniate.
    Faghihi G; Tavakoli-kia R
    Clin Exp Dermatol; 2003 Jan; 28(1):13-6. PubMed ID: 12558620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-ulcerative cutaneous leishmaniasis in Honduras fails to respond to topical paromomycin.
    Neva FA; Ponce C; Ponce E; Kreutzer R; Modabber F; Olliaro P
    Trans R Soc Trop Med Hyg; 1997; 91(4):473-5. PubMed ID: 9373659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of paromomicin and gentamicin patches in the treatment of cutaneous leishmaniasis.
    Asilian A; Faghihi G; Siadat AH; Hejazi H; Shahtalebi M; Sadeghian G; Mostaghim M; Radan MR
    East Mediterr Health J; 2006 Nov; 12(6):931-3. PubMed ID: 17333845
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effect of a hydrophilic formulation of topical paromomycin on cutaneous leishmaniasis among patients with contraindications for treatment with pentavalent antimonials].
    Santos AM; Noronha EF; Ferreira LA; Carranza-Tamayo CO; Cupolillo E; Romero GA
    Rev Soc Bras Med Trop; 2008; 41(5):444-8. PubMed ID: 19009183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Occlusive paromomycin for cutaneous leishmaniasis.
    Bell SA; Schaller M; Röcken M
    Lancet; 1997 Jan; 349(9044):29. PubMed ID: 8988124
    [No Abstract]   [Full Text] [Related]  

  • 18. Fluconazole for the treatment of cutaneous leishmaniasis.
    Zvulunov A; Klaus S; Vardy D
    N Engl J Med; 2002 Aug; 347(5):370-1; author reply 370-1. PubMed ID: 12151480
    [No Abstract]   [Full Text] [Related]  

  • 19. Occlusive paromomycin for cutaneous leishmaniasis.
    Bryceson AD
    Lancet; 1997 May; 349(9063):1477. PubMed ID: 9164342
    [No Abstract]   [Full Text] [Related]  

  • 20. Topical 15% Paromomycin-Aquaphilic for Bolivian Leishmania braziliensis Cutaneous Leishmaniasis: A Randomized, Placebo-controlled Trial.
    Soto J; Soto P; Ajata A; Luque C; Tintaya C; Paz D; Rivero D; Berman J
    Clin Infect Dis; 2019 Feb; 68(5):844-849. PubMed ID: 30260376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.